Company
Genprex, Inc. (GNPX)
Standardized SEC financial data for Genprex, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001595248 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-203.8%
Free cash flow
-$15.3M
Current ratio
3.84×
EPS (diluted)
$-17.40
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | — |
| R&D expense |
Balance sheet
| USD | FY2022 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | $21.0M | $6.7M | $1.6M | $7.8M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$13.9M | -$14.3M | -$17.6M | -$24.7M | -$17.9M | -$15.3M |
| Capital expenditures |
Get GNPX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/GNPX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/GNPX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"